An Open-label, Randomized, Single Dose, Two-period Crossover Study to Demonstrate Bioequivalence Between the Controlled Release Paroxetine Tablet (37.5 mg) Manufactured at Cidra and Mississauga
收藏DataCite Commons2025-05-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00000684/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This study is to determine if controlled release paroxetine tablets manufactured at two different sites behave similarly in healthy volunteers.
本研究旨在确定在两家不同生产场地生产的控释帕罗西汀片（controlled release paroxetine tablets）在健康受试者中的行为是否相似。
提供机构：
Vivli
创建时间：
2018-10-27
